Optimal cutoff value of basal anti-mullerian hormone in iranian infertile women for prediction of ovarian hyper-stimulation syndrome and poor response to stimulation

被引:15
作者
Aghssa, Malek Mansour [1 ]
Tarafdari, Azam Manshadi [1 ]
Tehraninejad, Ensieh Shahrokh [1 ]
Ezzati, Mohammad [2 ]
Bagheri, Maryam [1 ]
Panahi, Zahra [1 ]
Mahdavi, Saeed [3 ]
Abbasi, Mehrshad [4 ]
机构
[1] Univ Tehran Med Sci, Valiasr Hosp, Dept Obstet & Gynecol, Vali E Asr Reprod Hlth Res Ctr, Tehran 1419433141, Iran
[2] Washington Hosp Ctr, Dept Obstet & Gynecol, Washington, DC 20010 USA
[3] Saeed Med Labs, Tehran, Iran
[4] Univ Tehran Med Sci, Valiasr Hosp, Dept Nucl Med, Tehran, Iran
关键词
Assisted Reproductive Technology; Ovulation induction; Ovarian hyper-stimulation syndrome; Anti-mullerian hormone; ASSISTED REPRODUCTIVE TECHNOLOGY; IN-VITRO FERTILIZATION; HYPERSTIMULATION SYNDROME; MENSTRUAL-CYCLE; AMH; RESERVE; MARKER; FSH;
D O I
10.1186/s12978-015-0053-4
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Aim: We intended to establish the threshold of Anti-Mullerian Hormone (AMH) for detection of Ovarian Hyper-Stimulation Syndrome (OHSS) and poor response to treatment in Iranian infertile women. Methods: Pre-stimulation menstrual cycle day-3 hormonal indices including basal AMH values were measured in 105 infertile women aged 32.5 +/- 4.3 years. Patients underwent long GnRH agonist Controlled Ovarian Hyperstimulation (COH) in a referral infertility center (Tehran, Iran). The gonadotropin dose was determined based on the age and basal serum Follicular Stimulating Hormone (FSH) level. The IVF/ICSI cycles were followed and the clinical and sonographic data were recorded. Results: Sixteen cases developed OHSS. The prevalence of PCOS was higher in subjects with OHSS [62.5 % (38.8-86.2) vs. 17 % (9.2-24.9)]. The patients with OHSS had higher ovarian follicular count [23.7 (3.2) vs. 9.1 (0.5); p < 0.05], collected oocytes [13.5 (1.9) vs. 6.9 (0.5); p < 0.05] and AMH level [7.9 (0.7) vs. 3.6 (0.3); p < 0.05]. Basal AMH level and oocyte yields (but not age, BMI, and PCOS) correlated with occurrence of OHSS; and only the AMH levels were associated with poor ovarian response (oocytes yield <= 4). The optimal cutoff value for the prediction of OHSS was 6.95 ng/ml (area under the receiver operating characteristics curve: 0.86; CI: 0.78-0.95; sensitivity: 75 %; specificity: 84 %; odds ratio for occurrence of OHSS: 9 and p < 0.001). The optimal cut point to discriminate poor response (oocytes <= 4) was 1.65 ng/ml (AUC : 0.8; CI: 0.69-0.91; sensitivity: 89 % specificity : 71 %; and OR = 23.8 and P value < 0.001). Conclusions: Iranian women with basal AMH level > 6.95 ng/ml are at high risk of developing OHSS and those with AMH level < 1.65 ng/ml are poor responders.
引用
收藏
页数:8
相关论文
共 28 条
[1]   Prediction of high ovarian response to controlled ovarian hyperstimulation: anti-Mullerian hormone versus small antral follicle count (2-6 mm) [J].
Aflatoonian, Abbas ;
Oskouian, Homa ;
Ahmadi, Shahnaz ;
Oskouian, Leila .
JOURNAL OF ASSISTED REPRODUCTION AND GENETICS, 2009, 26 (06) :319-325
[2]   Risk factors for ovarian hyperstimulation syndrome in Thai patients using gonadotropins for in vitro fertilization [J].
Aramwit, Pornanong ;
Pruksananonda, Kamthorn ;
Kasettratat, Narat ;
Jammeechai, Karnphat .
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2008, 65 (12) :1148-1153
[3]   AMH and AFC as predictors of excessive response in controlled ovarian hyperstimulation: a meta-analysis [J].
Broer, S. L. ;
Dolleman, M. ;
Opmeer, B. C. ;
Fauser, B. C. ;
Mol, B. W. ;
Broekmans, F. J. M. .
HUMAN REPRODUCTION UPDATE, 2011, 17 (01) :46-54
[4]   Basal level of anti-Mullerian hormone is associated with oocyte quality in stimulated cycles [J].
Ebner, T. ;
Sommergruber, M. ;
Moser, M. ;
Shebl, O. ;
Schreier-Lechner, E. ;
Tews, G. .
HUMAN REPRODUCTION, 2006, 21 (08) :2022-2026
[5]   Dynamic assays of inhibin B, anti-Mullerian hormone and estradiol following FSH stimulation and ovarian ultrasonography as predictors of IVF outcome [J].
Eldar-Geva, T ;
Ben-Chetrit, A ;
Spitz, IM ;
Rabinowitz, R ;
Markowitz, E ;
Mimoni, T ;
Gal, M ;
Zylber-Haran, E ;
Margalioth, EJ .
HUMAN REPRODUCTION, 2005, 20 (11) :3178-3183
[6]   How to avoid ovarian hyperstimulation syndrome: a new indication for dopamine agonists [J].
Garcia-Velasco, Juan A. .
REPRODUCTIVE BIOMEDICINE ONLINE, 2009, 18 :S71-S75
[7]  
Golan A, 1989, Obstet Gynecol Surv, V44, P430, DOI 10.1097/00006254-198906000-00004
[8]   Anti-Mullerian hormone levels in the spontaneous menstrual cycle do not show substantial fluctuation [J].
Hehenkamp, Wouter J. K. ;
Looman, Caspar W. N. ;
Themmen, Axel P. N. ;
de Jong, Frank H. ;
te Velde, E. R. ;
Broekmans, Frank J. M. .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2006, 91 (10) :4057-4063
[9]   Prediction of ovarian hyperstimulation syndrome in women undergoing in vitro fertilization [J].
Kahnberg, Annika ;
Enskog, Anders ;
Brannstrom, Mats ;
Lundin, Kersti ;
Bergh, Christina .
ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 2009, 88 (12) :1373-1381
[10]   Anti-mullerian hormone and cumulative pregnancy outcome in in-vitro fertilization [J].
Kini, Suresh ;
Li, H. W. Raymond ;
Morrell, Dave ;
Pickering, Sue ;
Thong, K. Joo .
JOURNAL OF ASSISTED REPRODUCTION AND GENETICS, 2010, 27 (08) :449-456